We are live on ! Find out more
IBIO icon

iBio
IBIO

19 hedge funds and large institutions have $2.25M invested in iBio in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

19% more funds holding

Funds holding: 16 → 19 (+3)

4% more capital invested

Capital invested by funds: $2.16M → $2.25M (+$91K)

0% less ownership

Funds ownership: 0% → 0% (-0%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$51.6K
2
Millennium Management
Millennium Management
New York
+$31.5K
3
RJA
Raymond James & Associates
Florida
+$28.7K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$8.6K
5
Bank of America
Bank of America
North Carolina
+$5.73K

Top Sellers

Rank Fund Capital Flow
1
PAMG
Patton Albertson Miller Group
Tennessee
-$28K
2
VKH
Virtu KCG Holdings
New York
-$15K
3
Citadel Advisors
Citadel Advisors
Florida
-$11.5K
4
UBS Group
UBS Group
Switzerland
-$8.6K
5
KTC
Kistler-Tiffany Companies
Pennsylvania
-$1K

IBIO Hedge Fund Activity: Q1 2016 in Review

19 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q1 2016, worth a combined $2.25M — up 4.2% from $2.16M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new IBIO positions and 2 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $51.6K. The largest seller was Patton Albertson Miller Group, exiting entirely with an estimated $28K sold.

  • 19 institutional investors held iBio (IBIO) as of Q1 2016, up from 16 in Q4 2015.
  • Funds reported $2.25M of iBio stock for Q1 2016, up 4.2% quarter-over-quarter.
  • 5 funds opened new iBio positions in Q1 2016 and 2 closed out, a net change of +3 holders.
  • The largest iBio buyer in Q1 2016 was Goldman Sachs, an estimated $51.6K added.
  • The largest iBio seller in Q1 2016 was Patton Albertson Miller Group, an estimated $28K sold.

Based on aggregated 13F filings for Q1 2016.